AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling
Abstract Adenoid cystic carcinoma (ACC) is an aggressive salivary gland malignancy with limited treatment options for recurrent or metastatic disease. Due to chemotherapy resistance and lack of targeted therapeutic approaches, current treatment options for the localized disease are limited to surger...
Main Authors: | Renata Ferrarotto, Vasudha Mishra, Elad Herz, Adar Yaacov, Oz Solomon, Rami Rauch, Adi Mondshine, Maria Motin, Tal Leibovich-Rivkin, Matti Davis, Joel Kaye, Christopher R. Weber, Le Shen, Alexander T. Pearson, Ari J. Rosenberg, Xiangying Chen, Alka Singh, Jon C. Aster, Nishant Agrawal, Evgeny Izumchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05133-9 |
Similar Items
-
Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?
by: Sophia Uddin, et al.
Published: (2022-02-01) -
γ-secretase inhibitors and modulators induce distinct conformational changes in the active sites of γ-secretase and signal peptide peptidase
by: Gertsik, Natalya, et al.
Published: (2015) -
Different chemically substituted chitooligosaccharides inhibit beta-secretase activity
by: Ahmed, A.B.A., et al.
Published: (2011) -
Specific Mutations in Aph1 Cause γ-Secretase Activation
by: Hikari Watanabe, et al.
Published: (2022-01-01) -
Synaptic and endosomal localization of active gamma-secretase in rat brain.
by: Susanne Frykman, et al.
Published: (2010-01-01)